B-Cell-Depleting Induction Therapy and Acute Cellular Rejection

被引：205

作者：

Clatworthy, Menna R. ^{[1
]}

Watson, Christopher J. E. ^{[1
]}

Plotnek, Gemma ^{[1
]}

Bardsley, Vicky ^{[1
]}

Chaudhry, Afzal N. ^{[1
]}

Bradley, J. Andrew ^{[1
]}

Smith, Kenneth G. C. ^{[1
]}

机构：

[1] Univ Cambridge, Sch Clin Med, Cambridge CB2 2QQ, England

来源：

NEW ENGLAND JOURNAL OF MEDICINE | 2009年 / 360卷 / 25期

基金：

英国惠康基金;

关键词：

RITUXIMAB;

D O I：

10.1056/NEJMc0808481

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：2683 / 2685

页数：3

共 5 条

[1] Rituximab, anti-CD20, induces in vivo cytokine release but does not impair ex vivo T-cell responses [J].

Agarwal, A ;

Vieira, CA ;

Book, BK ;

Sidner, RA ;

Fineberg, NS ;

Pescovitz, MD .

AMERICAN JOURNAL OF TRANSPLANTATION, 2004, 4 (08) :1357-1360

[2] B-cell depletion with Rituximab in relapsing-remitting multiple sclerosis [J].

Hauser, Stephen L. ;

Waubant, Emmanuelle ;

Arnold, Douglas L. ;

Vollmer, Timothy ;

Antel, Jack ;

Fox, Robert J. ;

Bar-Or, Amit ;

Panzara, Michael ;

Sarkar, Neena ;

Agarwal, Sunil ;

Langer-Gould, Annette ;

Smith, Craig H. .

NEW ENGLAND JOURNAL OF MEDICINE, 2008, 358 (07) :676-688

[3] Regulatory B cells inhibit EAE initiation in mice while other B cells promote disease progression [J].

Matsushita, Takashi ;

Yanaba, Koichi ;

Bouaziz, Jean-David ;

Fujimoto, Manabu ;

Tedder, Thomas F. .

JOURNAL OF CLINICAL INVESTIGATION, 2008, 118 (10) :3420-3430

[4] Interleukin-2-receptor blockade with daclizumab to prevent acute rejection in renal transplantation [J].

Vincenti, F ;

Kirkman, R ;

Light, S ;

Bumgardner, G ;

Pescovitz, M ;

Halloran, P ;

Neylan, J ;

Wilkinson, A ;

Ekberg, H ;

Gaston, R ;

Backman, L ;

Burdick, J .

NEW ENGLAND JOURNAL OF MEDICINE, 1998, 338 (03) :161-165

[5] To B or Not to B? B-cells and graft rejection [J].

Zarkhin, Valeriya ;

Li, Li ;

Sarwal, Minnie .

TRANSPLANTATION, 2008, 85 (12) :1705-1714

← 1 →